CompletedNCT05531591
Depression treatment and brain markers linked to dementia risk
About this title
Read the official source — NCT05531591Medication studyAges 60+United States + Canada
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: from 60 years. Other eligibility criteria applied.
- Listed locations
- Los Angeles and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: August 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 87
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States, Canada
- Age range
- Over 60 Years
- Official registry ID
- NCT05531591
- Official title
Show the full official title
RCT of Neurocognitive and Neuroimaging Biomarkers: Predicting Progression Towards Dementia in Patients With Treatment-resistant Late-life Depression (OPTIMUM-Neuro RCT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles, United States · St Louis, United States · New York, United States
1 more locations
- Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion, Lithium Augmentation and Switch to nortriptyline.
Who was this study for?
This study was for people with depression. Listed age limits: from 60 years. Other eligibility criteria applied.
